Evolent Health (EVH) vs Franklin Covey (FC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Evolent Health (EVH) has outperformed Franklin Covey (FC) over the past year, losing 5.8% versus a loss of 12.4%. Over five years, FC leads with a -70.8% price change compared with -85.2% for EVH. Evolent Health is the larger company by market cap ($441.1 million vs $149.5 million), about 3.0 times the size, while Franklin Covey is growing revenue faster (-2.1% vs -26.6%).
On valuation, Franklin Covey trades at a lower forward P/E (7.8x vs 9.2x for Evolent Health). Franklin Covey converts more of its revenue into profit, with a net margin of 1.9% versus -28.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVH | FC |
|---|---|---|
| Share price | $3.90 | $13.19 |
| Market cap | $441.11M | $149.51M |
| 1-day change | +13.70% | +0.61% |
| YTD return | -2.50% | -21.39% |
| 1-year return | -5.80% | -12.36% |
| 5-year return | -85.16% | -70.79% |
| P/E ratio (TTM) | — | 31.40 |
| Forward P/E | 9.22 | 7.83 |
| EPS (TTM) | $-4.46 | $0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.88B | $261.45M |
| Revenue growth (YoY) | -26.56% | -2.10% |
| Net income (latest FY) | $-534.51M | $4.92M |
| Gross margin | 21.31% | 74.98% |
| Operating margin | -21.86% | 2.74% |
| Net margin | -28.49% | 1.88% |
| 52-week high | $6.26 | $26.81 |
| 52-week low | $2.10 | $11.16 |
| Distance from 52-week high | -37.65% | -50.80% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +53.85% | +97.57% |
| Average volume | 2.16M | 64.41K |
| Shares outstanding | 113.11M | 11.34M |
| Employees | 4,200 | 1,010 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Other Consumer Services | Other Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Evolent Health is about 3.0 times larger than Franklin Covey by market value ($441.11M vs $149.51M).
- Franklin Covey is more profitable, keeping 1.9 cents of every revenue dollar as net income versus -28.5 cents for Evolent Health.
- Franklin Covey grew revenue faster in its latest fiscal year (-2.10% vs -26.56%).
About Evolent Health
EVH stock →Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management.
Consumer Discretionary · Other Consumer Services · 4,200 employees
About Franklin Covey
FC stock →Franklin Covey Co. provides training and consulting services and related products in Australia, Austria, China, France, Germany, Ireland, Japan, New Zealand, Switzerland, the United States, Canada, and the United Kingdom.
Consumer Discretionary · Other Consumer Services · 1,010 employees
EVH vs FC FAQ
Which is bigger, Evolent Health or Franklin Covey?
Evolent Health (EVH) is larger, with a market capitalization of $441.11M compared with $149.51M for Franklin Covey (FC).
Which stock has performed better over the past year, EVH or FC?
EVH returned -5.80% over the past 12 months, compared with -12.36% for FC (price return, excluding dividends). Past performance does not predict future results.
Are Evolent Health and Franklin Covey in the same industry?
Yes. Both are classified in the Other Consumer Services industry within the Consumer Discretionary sector.